Please use this identifier to cite or link to this item: https://www.arca.fiocruz.br/handle/icict/50741
Title: SARS-CoV-2 Variants of Interest and Concern naming scheme conducive for global discourse
Authors: Konings, Frank
Perkins, Mark D.
H. Kuhn, Jens H.
Pallen, Mark J.
Alm, Erik J.
Archer, Brett N.
Barakat, Amal
Bedford, Trevor Bedford
Bhiman, Jinal N.
Caly, Leon
Carter, Lisa L.
Cullinane, Anne
Oliveira, Tulio de
Druce, Julian
Masry, Ihab El
Evans, Roger
Gao, George F.
Gorbalenya, Alexander E.
Hamblion, Esther
Herring, Belinda L.
Hodcroft, Emma
Holmes, Edward C.
Kakkar, Manish
Khare, Shagun
Koopmans, Marion P. G.
Korber, Bette
Leite, Juliana
MacCannell, Duncan
Marklewitz, Marco
Maurer-Stroh, Sebastian
Rico, Jairo Andres Mendez
Munster, Vincent J.
Neher, Richard
Munnink, Bas Oude
Pavlin, Boris I.
Peiris, Malik
Poon, Leo
Pybus, Oliver
Rambaut, Andrew
Resende, Paola
Subissi, Lorenzo
Thiel, Volker
Tong, Suxiang
van der Werf, Sylvie
von Gottberg, Anne
Ziebuhr, John
Van Kerkhove, Maria D.
Affilliation: World Health Organization, Geneva, Switzerland.
World Health Organization, Geneva, Switzerland.
Integrated Research Facility at Fort Detrick, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick, Frederick, MD, USA.
Quadram Institute Bioscience, University of East Anglia. Norwich, UK.
European Centre for Disease Prevention and Control. Stockholm, Sweden.
World Health Organization, Geneva, Switzerland.
World Health Organization, Geneva, Switzerland.
Fred Hutchinson Cancer Research Center. Seattle, WA, USA.
National Institute for Communicable Diseases. Johannesburg, South Africa / School of Pathology, Faculty of Health Sciences, University of the Witwatersrand. Johannesburg, South Africa.
Victorian Infectious Diseases Reference Laboratory (VIDRL). Melbourne, Victoria, Australia.
World Health Organization, Geneva, Switzerland.
Faculty of Science and Engineering, University of Limerick. Limerick, Ireland.
University of KwaZulu-Natal. Durban, South Africa.
Victorian Infectious Diseases Reference Laboratory (VIDRL). Melbourne, Victoria, Australia.
Emergency Centre for Transboundary Animal Disease, Food and Agriculture Organization of the United Nations (FAO).Cairo, Egypt.
World Health Organization, Geneva, Switzerland.
Chinese Center for Disease Control and Prevention. Beijing, P.R. China.
Leiden University Medical Center. Leiden, The Netherlands / Faculty of Bioengineering and Bioinformatics. Lomonosov Moscow State University, Moscow, Russia.
World Health Organization, Geneva, Switzerland.
World Health Organization, Geneva, Switzerland.
University of Bern. Bern, Switzerland.
The University of Sydney. Sydney, New South Wales, Australia.
World Health Organization, Geneva, Switzerland.
World Health Organization, Geneva, Switzerland.
Erasmus University. Rotterdam, The Netherlands.
Theoretical Biology and Biophysics. Los Alamos National Laboratory. Los Alamos, NM, USA.
World Health Organization, Geneva, Switzerland.
United States Centers for Disease Control and Prevention. Atlanta, GA, USA.
World Health Organization, Geneva, Switzerland.
The Global Initiative on Sharing All Influenza Data (GISAID). Munich, Germany / Bioinformatics Institute, Agency for Science, Technology and Research. Singapore, Singapore.
World Health Organization, Geneva, Switzerland.
Virus Ecology Unit, National Institute of Allergy and Infectious Diseases. Rockville, MA, USA.
Biozentrum, University of Basel, Switzerland Swiss Institute of Bioinformatics. Basel, Switzerland.
Erasmus University. Rotterdam, The Netherlands.
World Health Organization, Geneva, Switzerland.
The University of Hong Kong. Hong Kong, China
The University of Hong Kong. Hong Kong, China.
University of Oxford, Oxford. United Kingdom.
Institute for Evolutionary Biology, Ashworth Laboratories. University of Edinburgh. Edinburgh, UK.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Vírus Respiratório e do Sarampo. Rio de Janeiro, RJ, Brasil.
World Health Organization, Geneva, Switzerland.
University of Bern. Bern, Switzerland / Institute of Virology and Immunology, Mittelhäusern, Switzerland.
United States Centers for Disease Control and Prevention. Atlanta, GA, USA.
Institut Pasteur. Paris, France.
National Institute for Communicable Diseases. Johannesburg, South Africa / School of Pathology, Faculty of Health Sciences, University of the Witwatersrand. Johannesburg, South Africa.
Institute of Medical Virology. Justus Liebig University Giessen, Giessen, Germany.
World Health Organization, Geneva, Switzerland.
Abstract: A group convened and led by the Virus Evolution Working Group of the World Health Organization reports on its deliberations and announces a naming scheme that will enable clear communication about SARS-CoV-2 variants of interest and concern. Conclusion: We emphasize that the existing phylogenetics-based nomenclature systems of SARS-CoV-2 lineages convey important information and continue to inform research. This new naming system is intended to facilitate the sharing of research advancements with a broader audience and aims to provide a platform to enable clear global discourse around VOIs and VOCs.
Keywords: SARS-CoV-2
Varaints of Interest
Concern naming scheme
Global discourse
COVID-19
keywords: SARS-CoV-2
Variantes de interesse e preocupação
Esquema de Nomenclatura próprio
Discurso global
COVID-19
Issue Date: 2021
Publisher: Nature
Citation: KONINGS, Frank et al. SARS-CoV-2 Variants of Interest and Concern naming scheme conducive for global discourse. Nature Microbiology, v. 6, p. 1-3, July 2021.
DOI: 10.1038/s41564-021-00932-w
ISSN: 2058-5276
Copyright: open access
Appears in Collections:IOC - Artigos de Periódicos
Files in This Item:
File Description SizeFormat 
Paola_Rezende_etal_IOC_2021.pdf766.97 kBAdobe PDFView/Open



FacebookTwitterDeliciousLinkedInGoogle BookmarksBibTex Format mendeley Endnote DiggMySpace

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.